News
The Switch is still only a little over a month and a half old and flying off the shelves, but how does Nintendo plan to shape the near future?
The company reported earnings per share of 79 cents for the quarter. "We delivered a strong start to FY26, outperforming ...
22h
SB Nation on MSNRutgers Rebuild: Key Players to Watch for the 2025-26 Basketball Season
The Rutgers’ 2025 basketball class features a promising mix of athleticism and skill as four prospects have officially signed ...
Whether updating monolithic systems, outdated frameworks or hardcoded business logic, modernization needs a clear roadmap and ...
These LPs, EPs, and mixtapes showcase The Alchemist producing classic releases for one artist or a consistent duo. No beat ...
Experience Level Objectives (XLOs) represent a fundamental evolution in monitoring philosophy, moving beyond the conventional ...
XPLR Infrastructure's shift in strategy and current low valuation present a compelling long-term investment opportunity in ...
PreludeI posted a thread on TeamBHP about two years ago now.TLDR: I wanted a proper commuter bike which could handle traffic ...
Microsoft's growth is driven by Copilot adoption, margin expansion, and strong earnings. Click to read more about a key ...
16h
Zacks Investment Research on MSNVertex Gears Up to Report Q2 Earnings: Is a Beat in the Cards?
We expect Vertex Pharmaceuticals VRTX to surpass expectations when it reports its second-quarter 2025 results on Aug. 4, ...
The company sees 2025 adjusted earnings of ‘at least’ $16 a share and revenue in the range of $445.5 billion to $448 billion.
Novo has been hit by copycats of its GLP-1 drugs Wegovy for weight-loss and Ozempic for diabetes. US law bars pharmacies from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results